RNAZ Financial Statements

Balance sheet, income statement, cash flow, and dividends for Transcode Therapeutics Inc (RNAZ).


$3.31M Market Cap.

As of 04/01/2024 5:00 PM ET (MRY) • Disclaimer

RNAZ Market Cap. (MRY)


RNAZ Shares Outstanding (MRY)


RNAZ Assets (MRY)


Total Assets

$5.17M

Total Liabilities

$3.53M

Total Investments

$0

RNAZ Income (MRY)


Revenue

$0

Net Income

-$18.55M

Operating Expense

$19.42M

RNAZ Cash Flow (MRY)


CF Operations

-$18.07M

CF Investing

-$35.61K

CF Financing

$15.91M

RNAZ Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

0%

0%

-

2019

$0

-

-

0%

-

RNAZ Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$5,169,701 (-31.87%)

$7,587,986 (-66.92%)

$22,938,443 (2073.50%)

$1,055,368 (416.15%)

Assets Current

$4,455,444 (-39.62%)

$7,379,405 (-67.54%)

$22,732,175 (2634.81%)

$831,215 (306.52%)

Assets Non-Current

$714,257 (242.44%)

$208,581 (1.12%)

$206,268 (-7.98%)

$224,153 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$1,640,814 (-49.37%)

$3,240,696 (-84.12%)

$20,404,346 (698.68%)

-$3,408,232 (-207.11%)

Property Plant & Equipment Net

$602,401 (188.81%)

$208,581 (1.12%)

$206,268 (0%)

$0 (0%)

Cash & Equivalents

$2,767,598 (-44.30%)

$4,968,418 (-76.14%)

$20,825,860 (2415.15%)

$828,016 (304.96%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$27,057 (0%)

$0 (0%)

$30,528 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$360,229 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,051,259 (-29.81%)

$4,347,290 (73.64%)

$2,503,569 (518.38%)

$404,862 (543.23%)

Accumulated Retained Earnings (Deficit)

-$46,416,344 (-66.54%)

-$27,870,249 (-170.45%)

-$10,305,281 (-197.68%)

-$3,461,882 (-209.65%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$450,571 (0%)

$0 (0%)

$0 (0%)

$2,086,675 (124.90%)

Debt Current

$412,280 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$38,291 (0%)

$0 (0%)

$0 (0%)

$2,086,675 (124.90%)

Total Liabilities

$3,528,887 (-18.83%)

$4,347,290 (71.55%)

$2,534,097 (-43.23%)

$4,463,600 (239.63%)

Liabilities Current

$3,490,596 (-19.71%)

$4,347,290 (71.55%)

$2,534,097 (525.92%)

$404,862 (543.23%)

Liabilities Non-Current

$38,291 (0%)

$0 (0%)

$0 (0%)

$4,058,738 (224.36%)

RNAZ Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$7,154,986 (-15.16%)

$8,433,448 (148.25%)

$3,397,169 (668.34%)

$442,145 (91.77%)

Research & Development Expense

$12,263,530 (19.85%)

$10,232,366 (271.55%)

$2,753,966 (868.14%)

$284,459 (25.69%)

Operating Expenses

$19,418,516 (4.03%)

$18,665,814 (203.45%)

$6,151,135 (746.56%)

$726,604 (59.04%)

Interest Expense

$55,899 (0%)

$0 (0%)

$95,070 (-75.91%)

$394,573 (151.38%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

-$2,343,893 (-286.01%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

-$2,343,893 (-286.01%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

-$2,343,893 (-286.01%)

Weighted Average Shares

$179,006 (-72.41%)

$648,862 (54.02%)

$421,294 (81.74%)

$231,811 (0.00%)

Weighted Average Shares Diluted

$179,006 (-72.41%)

$648,862 (54.02%)

$421,294 (81.74%)

$231,811 (0.00%)

Earning Before Interest & Taxes (EBIT)

-$18,490,196 (-5.27%)

-$17,564,968 (-160.29%)

-$6,748,329 (-246.19%)

-$1,949,320 (-332.94%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$19,418,516 (-4.03%)

-$18,665,814 (-203.45%)

-$6,151,135 (-746.56%)

-$726,604 (-59.04%)

RNAZ Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$35,609 (64.72%)

-$100,919 (59.92%)

-$251,820 (0%)

$0 (0%)

Net Cash Flow from Financing

$15,909,324 (265542.41%)

$5,989 (-99.98%)

$25,516,549 (2185.37%)

$1,116,516 (123.30%)

Net Cash Flow from Operations

-$18,074,535 (-14.67%)

-$15,762,512 (-199.28%)

-$5,266,885 (-968.40%)

-$492,971 (3.06%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$2,200,820 (86.12%)

-$15,857,442 (-179.30%)

$19,997,844 (3107.12%)

$623,545 (7428.93%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$35,609 (64.72%)

-$100,919 (59.92%)

-$251,820 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$1,190,000 (138.00%)

Issuance (Purchase) of Equity Shares

$15,909,324 (265542.41%)

$5,989 (-99.98%)

$26,377,492 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,036,889 (162.29%)

$395,329 (112.55%)

$185,996 (309.29%)

$45,444 (3152.97%)

Depreciation Amortization & Accretion

$516,746 (424.05%)

$98,606 (132.18%)

$42,470 (0%)

$0 (0%)

RNAZ Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-934.70% (-444.38%)

-171.70% (-92.49%)

-89.20% (-185.93%)

103.80%

Return on Average Assets (ROAA)

-276.10% (-106.66%)

-133.60% (-148.33%)

-53.80% (85.54%)

-372.10%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

1790.40% (-20.09%)

2240.40% (475.65%)

-596.40% (-324.48%)

-140.50%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.06 (87.17%)

-0.5 (84.09%)

-3.14

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

2.02 (-25.08%)

2.69 (67.81%)

1.61

-

Debt to Equity Ratio (D/E)

2.15 (60.40%)

1.34 (981.45%)

0.12 (109.47%)

-1.31 (-10.64%)

Earnings Per Share (EPS)

-103.61 (-283.74%)

-27 (-66.67%)

-16.2 (-58.82%)

-10.2 (-292.31%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-101.17 (-313.82%)

-24.45 (-86.64%)

-13.1 (-515.84%)

-2.13 (3.05%)

Book Value Per Share (BVPS)

9.17 (83.54%)

4.99 (-89.69%)

48.43 (429.41%)

-14.7 (-207.14%)

Tangible Assets Book Value Per Share (TABVPS)

28.88 (146.96%)

11.69 (-78.52%)

54.45 (1095.87%)

4.55 (416.21%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-2

-

Enterprise Value Over EBITDA (EV/EBITDA)

0.2 (6466.67%)

0 (100.20%)

-1.53

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

1.28 (-24.81%)

1.7 (-81.08%)

8.97 (336.97%)

2.05 (-36.81%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$18,110,144 (-14.16%)

-$15,863,431 (-187.45%)

-$5,518,705 (-1019.48%)

-$492,971 (3.06%)

Enterprise Value (EV)

-$3,546,156 (-6136.43%)

-$56,862 (-100.55%)

$10,277,762

-

Earnings Before Tax (EBT)

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

-$2,343,893 (-286.01%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$17,973,450 (-2.90%)

-$17,466,362 (-160.46%)

-$6,705,859 (-244.01%)

-$1,949,320 (-332.94%)

Invested Capital

-$637,922 (63.08%)

-$1,727,722 (-309.88%)

-$421,514 (-122.08%)

$1,909,165 (120.75%)

Working Capital

$964,848 (-68.18%)

$3,032,115 (-84.99%)

$20,198,078 (4637.41%)

$426,353 (201.25%)

Tangible Asset Value

$5,169,701 (-31.87%)

$7,587,986 (-66.92%)

$22,938,443 (2073.50%)

$1,055,368 (416.15%)

Market Capitalization

$3,312,084 (-62.08%)

$8,733,678 (-73.35%)

$32,777,618

-

Average Equity

$1,984,095 (-80.60%)

$10,228,484 (33.36%)

$7,669,562 (439.51%)

-$2,259,008

Average Assets

$6,717,400 (-48.93%)

$13,152,258 (3.44%)

$12,714,722 (1918.47%)

$629,920

Invested Capital Average

-$1,032,743 (-31.73%)

-$784,008 (-169.29%)

$1,131,497 (-18.42%)

$1,387,016

Shares

502,440 (-22.57%)

648,862 (0.56%)

645,229 (7.83%)

598,354